USEUROPEAFRICAASIA 中文雙語Fran?ais
    China
    Home / China / Health

    Biopharmaceuticals seen as key driver for future growth

    By Wang Hongyi | China Daily | Updated: 2016-11-21 07:51

    Shanghai's Zhangjiang National Innovation Demonstration Zone is a huge repository of innovative resources helping to advance sector

    As the country accelerates its promotion of the biopharmaceutical industry in a bid to form a new economic growth driver, the Shanghai Zhangjiang National Innovation Demonstration Zone is working to build itself into a national leader for the advancement of this sector.

    The zone in Shanghai comprises 22 industrial parks and 124 sub-parks that are home to different industry clusters, such as new generation information technology, advanced facilities manufacturing, pharmaceuticals, as well as energy and environmental protection.

    Biopharmaceuticals seen as key driver for future growth

    It is also a massive repository for innovative resources contributed by the more than 70,000 enterprises that call the zone home. Over 2,670 of these are high-tech enterprises and more than 1,400 are research institutions.

    The biopharmaceutical industry in the zone has kept rising in recent years, becoming a pillar of Shanghai's pharmaceutical industry. According to the demonstration zone, chemical drugs still account for a larger proportion of the pharmaceutical industry in Zhangjiang, but the output value of biotech medicines has increased fast in recent years. In 2015, a total of 58 new drugs were approved to enter into clinical trial stages, including 44 chemical drugs, 10 biopharmaceutical medicines and four types of herbal medicine.

    In 2015, the total sales tax and profit of Zhangjiang's biopharmaceutical industry grew by 16.4 percent and 12.9 percent year-on-year, respectively.

    According to the National Bureau of Statistics, the main business income of Shanghai's biopharmaceutical industry accounted for about 2.9 percent of the country's total pharmaceutical industry in 2015.

    Figures from the city's statistics bureau show that the industrial output value of biopharmaceuticals from the Zhangjiang demonstration zone accounted for 66 percent of the city's total last year.

    In 2015, there were 167 major biopharmaceutical enterprises in Zhangjiang demonstration zone, nearly 60 percent of the city's total. Among them, 98 enterprises saw their core revenue exceed 100 million yuan ($14.53 million) and 12 enterprises' revenues exceeded 1 billion yuan. In addition, 16 of Shanghai's top 20 enterprises are from Zhangjiang, with their total industrial output value reaching 31 billion yuan, accounting for 47.5 percent of the demonstration zone's total and 34.3 percent of the city's biopharmaceutical industry's total.

    Following the city's threeyear action plan for development of the biopharmaceutical technology industry, initiated in 2014, the Zhangjiang zone is now actively promoting the construction of seven biopharmaceutical manufacturing bases across the city, in order to form a series of industry clusters. These cover such sub-sectors as modern Chinese medicine, biotech products, chemical drugs and medical equipment. The zone is also looking to build an advanced biomedical manufacturing base.

    Also, Zhangjiang now pays more attention to the development of service outsourcing, with a focus on Shanghai's Xuhui and Pudong districts. In 2014, Zhangjiang was identified as a vital element in Shanghai's planned transformation into a global science and technology innovation hub with significant influence on a global scale. Speeding up the pace of innovation and growth in the biopharmaceuticals industry has become an important part to realize that ambition.

    "Over the past two decades, Zhangjiang has been playing an increasingly important role in boosting innovation and promoting transformation," said Cao Zhenquan, deputy director of the Shanghai Zhangjiang National Innovation Demonstration Zone. He noted that the zone will continue to optimize its industry environment and create an innovative ecosystem to support emerging industries' further development, such as biopharmaceuticals, precision medicines and big data in medicine.

     Biopharmaceuticals seen as key driver for future growth

    Researchers operate a machine for protein purification at a biotech lab in the Shanghai Zhangjiang National Innovation Demonstration Zone.Xinhua

    Editor's picks
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    久久久久亚洲av无码专区喷水| 无码人妻视频一区二区三区| 久久精品无码午夜福利理论片| 久久亚洲精品中文字幕| 久久久久久人妻无码| 成人无码区免费A片视频WWW| 激情欧美一区二区三区中文字幕| 国产精品亚洲αv天堂无码| 亚洲第一极品精品无码久久| 亚洲午夜无码AV毛片久久| AAA级久久久精品无码区| 亚洲av无码片在线播放| 久久久无码精品亚洲日韩京东传媒| 亚洲精品中文字幕乱码三区 | 国产精品99久久久精品无码| 日韩视频无码日韩视频又2021 | 无码h黄动漫在线播放网站| 日韩va中文字幕无码电影| 久久综合中文字幕| 天堂资源中文最新版在线一区 | 人妻少妇精品视中文字幕国语| 久久久久亚洲?V成人无码| YW尤物AV无码国产在线观看| 无码人妻精品一区二区三区在线| 暴力强奷在线播放无码| 最新中文字幕av无码专区| A级毛片无码久久精品免费| 天堂Aⅴ无码一区二区三区| 无码人妻精品一区二区三区99性| 久久精品?ⅴ无码中文字幕 | 无码不卡av东京热毛片| 亚洲精品人成无码中文毛片 | 中文字幕人妻无码一夲道| 久久精品中文无码资源站| 国产成人精品一区二区三区无码| 中文字幕日韩第十页在线观看| 久久久噜噜噜久久中文字幕色伊伊| 亚洲欧美日韩中文字幕一区二区| 日本中文字幕高清| 亚洲国产AV无码专区亚洲AV| 人妻丰满熟妇av无码区不卡|